ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Regis Resources Ltd

Regis Resources Ltd (RKQ)

1.007
0.00
( 0.00% )
Updated: 12:01:32
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.007
Bid
0.9952
Ask
1.0285
Volume
0.00
0.00 Day's Range 0.00
0.8652 52 Week Range 1.3695
Previous Close
1.007
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
10,922
Financial Volume
-
VWAP
-

RKQ Latest News

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions

BERKELEY HEIGHTS, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...

Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting

 - Novel CDK2/9 inhibitor fadraciclib induces anaphase catastrophe, a novel cancer-specific mechanism of action - BERKELEY HEIGHTS, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Cyclacel...

Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib’s Potential as a Precision Medicine for Cancer

- Clinical, PK and PD data from novel CDK2/9 inhibitor fadraciclib monotherapy studies support ongoing proof of concept study in patients with solid tumors and lymphoma - BERKELEY HEIGHTS, N.J...

Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update

- New Clinical Data to be Presented at ASCO Annual Meeting Highlighting Potential Precision Medicine Strategy with Oral Fadraciclib -- First Patients Enrolled in Oral Fadraciclib Phase 2 Proof of...

Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results

BERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...

Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules

BERKELEY HEIGHTS, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...

$8 Million Private Placement Announcement Sends Biotech Flying

Usually when a publicly traded company announces some sort of equity offering, it can be viewed as a dilutive event, thus having a negative effect on the company’s price per To read the full...

Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

BERKELEY HEIGHTS, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...

Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer

- New clinical, PK and PD data from novel CDK2/9 inhibitor fadraciclib monotherapy studies support ongoing development program in patients with solid tumors and lymphoma - BERKELEY HEIGHTS, N.J...

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

– On Track to Start Oral Fadraciclib Phase 2 Proof of Concept in 1H 2024 – – Expect to Report Final Data from Fadraciclib 065-101 Dose Escalation – – Oral Plogosertib Preclinical Data Support...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1529999-13.18964768881.15999991.16050.975672871.04406913DE
4-0.083-7.614678899081.091.1910.975688601.13416692DE
12-0.2735-21.35884420151.28051.31949990.9756109221.17930203DE
26-0.2385-19.14893617021.24551.3620.9756104691.2138934DE
520.02943.007364975450.97761.36950.8652100651.1789005DE
1560.02943.007364975450.97761.36950.8652100651.1789005DE
2600.02943.007364975450.97761.36950.8652100651.1789005DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
9S70Critical Resources Limited
0.006 €
(50.00%)
166.67k
BDDConico Ltd
0.0008 €
(33.33%)
125k
PW2Powell Industries, Inc.
161.20 €
(30.74%)
611
OY4Mogotes Metals Inc
0.111 €
(30.13%)
798.11k
0LSBurgerFi International Inc
0.65 €
(30.00%)
40.52k
CBOImunon Inc
1.43 €
(-53.27%)
53.75k
1FGFibroGen Inc
0.4858 €
(-49.27%)
73.21k
HHHAHomes & Holiday AG
0.07 €
(-48.15%)
240
EJ7Energy Resources of Australia
0.009 €
(-35.72%)
252k
T0UTC BioPharm Holdings plc
0.55 €
(-35.67%)
38.72k
D7GNel ASA
0.5088 €
(-1.40%)
2.16M
DMLSayona Mining Limited
0.019 €
(3.83%)
1.07M
LHADeutsche Lufthansa AG
5.774 €
(-2.24%)
1.06M
NVDNVIDIA Corp
107.18 €
(11.94%)
802.85k
OY4Mogotes Metals Inc
0.111 €
(30.13%)
798.11k

Discussion

View Full Feed
Tomorrowneverknows Tomorrowneverknows 26 seconds ago
Exactly
HIRU
wakeupdummy wakeupdummy 30 seconds ago
they got another good quote.....
"we're all sickypoo and it may be another week"
i for one am sending over some chicken soup.
IDVV
luckydude777 luckydude777 33 seconds ago
Nice alert. Thanks.
Ms Labonte Ms Labonte 38 seconds ago
$lap my a$$ and cal me $weet$$$ I love you $weet$$
LAP WEET
ANTI-BAGHOLDER ANTI-BAGHOLDER 44 seconds ago
lol I figured you wouldn’t do it. All this talk and nothing…
MONI
bb8675309 bb8675309 51 seconds ago
Nice post bas - A Comparison of the ADAS-Cog Scores for Aducanumab, Blarcamesine, Donanemab and Lecanemab!
2024 07/30 👏

Conclusions
Clearly, from this chart Blarcamesine has substantially better performance than the other drugs. The Blarcamesine trial had no incl
AVXL
stealofadeal stealofadeal 53 seconds ago
$GEVI Great entry price today and some are getting scooped up now.
GEVI
Monksdream Monksdream 1 minute ago
SYTA new 52 week low
https://investorshub.advfn.com/uimage/uploads/2024/7/31/dcopfIMG_0177.gif
SYTA
3331 3331 1 minute ago
Bioelectronics (BIEL) - NEW CONTRACT - ready for blast off, CEO says "there is an agreement that requires our silence. That is all I can say".
1) Golden Cross and Blue Skies Breakout Imminent! The 50 dma is .0001, 200 dma is .0002, yearly high is .0005.
2) Profitabity: BIEL has cut
Nebuchadnezzar Nebuchadnezzar 1 minute ago
will nibble at .0025

fyi AMC is going to go nuts on friday
HIRU
redspeed redspeed 1 minute ago
I have calls in the afternoon. You can asked them for me.

Also if there is time, ask them why they use Google for searching😂
MONI
ScottishTexan ScottishTexan 1 minute ago
Looks like you were right and I stand corrected. I am not a basher nor a pumper. Just a small retail player trying to make a buck. GLTA.
IGPK
WilliamMunny WilliamMunny 2 minutes ago
In December of last year Anavex got approval to use the centralized procedure. There are no submissions taken for Rapporteur appointment in the month of December (and it would have been too late anyway at that point). Perhaps because of the scant time and end of year issues, they didn't hit the ea
AVXL
goldbarren58 goldbarren58 2 minutes ago
feel screwed again yet?
NWPN
ANTI-BAGHOLDER ANTI-BAGHOLDER 2 minutes ago
I told you. There is going to be around 200+ million sold.
SINC
stealofadeal stealofadeal 2 minutes ago
$GEVI This stock trades unlike some.
GEVI
bar1080 bar1080 2 minutes ago
Boeing names Ortberg to replace Calhoun as BA CEO

https://www.bloomberg.com/news/articles/2024-07-31/boeing-names-kelly-ortberg-ceo-to-succeed-dave-calhoun
PonkenPlonken PonkenPlonken 2 minutes ago
MLGO 1.57 lets see if they game it lower prior to a real move
MLGO
ANTI-BAGHOLDER ANTI-BAGHOLDER 2 minutes ago
I see a real big opportunity here.
MONI
236T568 236T568 2 minutes ago
NBC News falling deeper in the hole

dissapointed
OzzyS85 OzzyS85 3 minutes ago
I just got my 40 virgins. More coming st .0031.
Weeeeeeeeeee
HIRU
stink stack stink stack 3 minutes ago
Smile, I see GREEN!
FMCC

Your Recent History

Delayed Upgrade Clock